首頁 > 市場調查報告書 > 製藥

糖尿病

市場調查報告書

商品編碼

1339241

糖尿病視網膜病變市場、份額、市場規模、趨勢、產業分析報告：按類型、按管理方法、按地區、細分市場趨勢，2023-2032

Diabetic Retinopathy Market Share, Size, Trends, Industry Analysis Report, By Type (Proliferative DR, Non-proliferative DR); By Management (Intraocular Steroid Injection, Laser Surgery, Vitrectomy); By Region, And Segment Forecasts, 2023 - 2032

出版日期: 2023年07月23日 | 出版商:

Polaris Market Research | 英文 116 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

根據Polaris Market Research的最新研究，到2032年，全球糖尿病視網膜病變市場規模預計將達到152.3億美元。該報告提供了對當前市場動態的詳細見解，並對未來市場成長進行了分析。

糖尿病的盛行率正在顯著增加，對全球健康產生重大影響。根據國際糖尿病聯盟的數據，2021年患有糖尿病的人數約為5.37億人。預計到 2030 年，這一數字將增加至 6.43 億，到 2045 年將達到驚人的 7.83 億。糖尿病被認為是全世界失明的主要原因之一。

糖尿病引起的失明通常是由於視網膜血管滲漏或破裂造成的損傷造成的。視力喪失的程度各不相同，從永久性到暫時性損害不等，取決於疾病的階段。一項研究顯示，預計2020年，糖尿病視網膜病變（一種由糖尿病引起的視力損害）患者數量將約為1.0312億。預計到 2045 年，這一數字將增加至約 1.605 億。

高齡化社會在醫療保健需求方面提出了獨特的挑戰，包括糖尿病等慢性病盛行率的增加。由於醫療進步和預期壽命的提高，預計 65 歲及以上的人口數量將大幅增加。例如，根據人口研究所的《美國老化》報告，美國65歲及以上的人口預計將從2016年的約4,600萬增加到2060年的9,800萬以上。

這種人口結構的變化強調了解決與老化相關的健康問題（包括糖尿病視網膜病變）的重要性。醫療保健提供者和市場製造商必須做好準備，以滿足不斷增長的人口不斷增長的需求，並提供有效的解決方案來管理糖尿病視網膜病變和保護老年人的視力。

COVID-19 大流行對世界各地的醫療保健系統產生了重大影響，包括糖尿病視網膜病變的診斷和治療。糖尿病視網膜病變的早期檢測和治療指南受到大流行期間施加的約束和限制的顯著影響。玻璃體內注射是糖尿病視網膜病變的常見治療方法，與 2019 年相比，疫情期間全球使用量顯著下降。減少率各不相同，但範圍從大約 30% 到超過 100%。

糖尿病視網膜病變市場報告亮點

由於糖尿病患者數量不斷增加，非增殖性糖尿病視網膜病變細分市場將在 2022 年佔據全球最高市場份額

抗VEGF藥物由於療效高、治療演算法好，佔最大份額

由於龐大的未開發人口和不斷提高的患者意識，亞太地區正在以最快的速度增長

糖尿病視網膜病變市場 - 產業概況
糖尿病視網膜病變市場動態
- 推動者和機會
  - 糖尿病盛行率不斷上升，糖尿病導致的失明率不斷上升
  - 提高對糖尿病護理和管理以及新產品發布的認識
- 抑制因素和挑戰
  - 成本高
杵分析
糖尿病視網膜病變的產業趨勢
價值鏈分析
COVID-19 感染的影響分析

第 5 章全球糖尿病視網膜病變市場（依類型）

主要發現
簡介
增殖性糖尿病視網膜病變
非增殖性糖尿病視網膜病變

第 6 章全球糖尿病視網膜病變市場（依管理方法）

主要發現
簡介
抗 VEGF
眼內類固醇注射
雷射手術
玻璃體手術

第 7 章全球糖尿病視網膜病變市場（按地區）

主要發現
簡介
- 2019-2032 年糖尿病視網膜病變市場評估（按地區）
糖尿病視網膜病變市場 - 北美
- 北美：糖尿病視網膜病變市場，依管理方式劃分，2019-2032 年
- 北美：2019-2032 年糖尿病視網膜病變市場（依類型）
- 糖尿病視網膜病變市場 - 美國
- 糖尿病視網膜病變市場 - 加拿大
糖尿病視網膜病變市場 - 歐洲
- 歐洲：糖尿病視網膜病變市場，依管理方式劃分，2019-2032 年
- 歐洲：糖尿病視網膜病變市場（按類型），2019-2032 年
- 糖尿病視網膜病變市場 - 英國
- 糖尿病視網膜病變市場 - 法國
- 糖尿病視網膜病變市場 - 德國
- 糖尿病視網膜病變市場 - 義大利
- 糖尿病視網膜病變市場 - 西班牙
- 糖尿病視網膜病變市場 - 荷蘭
- 糖尿病視網膜病變市場 - 俄羅斯
糖尿病視網膜病變市場 - 亞太地區
- 亞太地區：糖尿病視網膜病變市場，依管理方式劃分，2019-2032 年
- 亞太地區：2019-2032 年糖尿病視網膜病變市場（依類型）
- 糖尿病視網膜病變市場 - 中國
- 糖尿病視網膜病變市場 - 印度
- 糖尿病視網膜病變市場 - 馬來西亞
- 糖尿病視網膜病變市場 - 日本
- 糖尿病視網膜病變市場 - 印度尼西亞
- 糖尿病視網膜病變市場 - 韓國
糖尿病視網膜病變市場 - 中東和非洲
- 中東和非洲：糖尿病視網膜病變市場（按管理方法），2019-2032 年
- 中東和非洲：2019-2032 年糖尿病視網膜病變市場（按類型）
- 糖尿病視網膜病變市場 - 沙烏地阿拉伯
- 糖尿病視網膜病變市場 - 阿拉伯聯合大公國
- 糖尿病視網膜病變市場 - 以色列
- 糖尿病視網膜病變市場 - 南非
糖尿病視網膜病變市場 - 拉丁美洲
- 拉丁美洲：糖尿病視網膜病變市場，依管理方式劃分，2019-2032 年
- 拉丁美洲：2019-2032 年糖尿病視網膜病變市場（依類型）
- 糖尿病視網膜病變市場 - 墨西哥
- 糖尿病視網膜病變市場 - 巴西
- 糖尿病視網膜病變市場 - 阿根廷

第八章競爭態勢

擴張與收購分析
- 放大
- 收購
夥伴關係/協作/協議/揭露

第九章公司簡介

Bayer
Allergan
Novartis
Oxurion
Sirnaomics
Genentech
Alimera Sciences
Ampio Pharmaceuticals
BCN Peptides
Kowa Company

簡介目錄圖表

Product Code: PM3621

The global diabetic retinopathy market size is expected to reach USD 15.23 billion by 2032, according to a new study by Polaris Market Research. The report "Diabetic Retinopathy Market Share, Size, Trends, Industry Analysis Report, By Type (Proliferative DR, Non-proliferative DR); By Management (Intraocular Steroid Injection, Laser Surgery, Vitrectomy); By Region, And Segment Forecasts, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The incidence of diabetes has been witnessing a significant surge, with a substantial impact on global health. According to the International Diabetes Federation, the number of individuals affected by diabetes was approximately 537 million in 2021. This figure is projected to increase to 643 million by 2030 and a staggering 783 million by 2045. Diabetes is recognized as one of the leading causes of blindness worldwide.

Blindness in individuals with diabetes is often attributed to the damage caused by leaking or ruptured blood vessels in the retina. The severity of vision loss can vary, ranging from permanent impairment to temporary disruptions depending on the stage of the disease. Research indicates that the number of cases of diabetic retinopathy, a specific form of vision impairment associated with diabetes, was estimated to be around 103.12 million in 2020. It is anticipated that the number of cases will escalate to approximately 160.5 million by 2045.

The aging population presents unique challenges in terms of healthcare needs, including a higher prevalence of chronic diseases like diabetes. With advancements in medical care and improved life expectancy, the number of individuals aged 65 years and over is projected to escalate substantially. For instance, the "Aging in the United States" report by the Population Reference Bureau indicates that the population of individuals aged 65 years and above in the U.S. is estimated to grow from approximately 46 million in 2016 to over 98 million by the year 2060.

This demographic shift underscores the importance of addressing health issues associated with aging, including diabetic retinopathy. Healthcare providers and manufacturers in the market must be prepared to meet the growing demands of this expanding population and provide effective solutions to manage diabetic retinopathy and preserve vision in older adults.

The COVID-19 pandemic had a substantial impact on healthcare systems worldwide, including the diagnosis and treatment of diabetic retinopathy. Due to the constraints and restrictions imposed during the pandemic, early detection and treatment guidelines for diabetic retinopathy were significantly affected. Intravitreal injections, which are a common treatment modality for diabetic retinopathy, experienced a significant decrease in usage globally during the pandemic compared to 2019. Reduction percentages varied but ranged from approximately 30% to over 100%.

Diabetic Retinopathy Market Report Highlights

Non-proliferative diabetic retinopathy segment accounted for highest global market share in 2022, due to rise in number of cases of diabetes

Anti-VEGF segment accounted largest share, due its high efficacy and better treatment algorithm

Asia Pacific region grown at the fastest rate, owing huge un-tapped population and better patient awareness

The global key market players include: Bayer, Allergan, Novartis, Oxurion, Sirnaomics, Genentech, Alimera Sciences, Ampio Pharmaceuticals, BCN Peptides, and Kowa Company.

Polaris Market Research has segmented the diabetic retinopathy market report based on type, management, and region:

Diabetic Retinopathy, Type Outlook (Revenue - USD Billion, 2019 - 2032)

Proliferative Diabetic Retinopathy
Non-proliferative diabetic retinopathy

Diabetic Retinopathy, Management Outlook (Revenue - USD Billion, 2019 - 2032)

Anti-VEGF
Intraocular Steroid Injection
Laser Surgery
Vitrectomy

Diabetic Retinopathy, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Latin America
Argentina
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Diabetic Retinopathy Market Insights

4.1. Diabetic Retinopathy Market - Industry Snapshot
4.2. Diabetic Retinopathy Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Rising prevalence of diabetes and increasing prevalence of blindness due to diabetes
  - 4.2.1.2. Growing awareness about diabetes care and management and new product launches
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High cost
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTLE Analysis
4.5. Diabetic Retinopathy Industry trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Diabetic Retinopathy Market, by Type

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Diabetic Retinopathy, by Type, 2019-2032 (USD Billion)
5.3. Proliferating Diabetic retinopathy
- 5.3.1. Global Diabetic Retinopathy Market, by Proliferating Diabetic retinopathy, by Region, 2019-2032 (USD Billion)
5.4. Non proliferating Diabetic Retinopathy
- 5.4.1. Global Diabetic Retinopathy Market, by Non proliferating Diabetic Retinopathy, by Region, 2019-2032 (USD Billion)

6. Global Diabetic Retinopathy Market, by Management

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
6.3. Anti VEGF
- 6.3.1. Global Diabetic Retinopathy Market, by Anti VEGF, by Region, 2019-2032 (USD Billion)
6.4. Intraocular Steroid Injection
- 6.4.1. Global Diabetic Retinopathy Market, by Intraocular Steroid Injection, by Region, 2019-2032 (USD Billion)
6.4. Laser Surgery
- 6.4.1. Global Diabetic Retinopathy Market, by Laser Surgery, by Region, 2019-2032 (USD Billion)
6.5. Vitrectomy
- 6.5.1. Global Diabetic Retinopathy Market, by Vitrectomy, by Region, 2019-2032 (USD Billion)

7. Global Diabetic Retinopathy Market, by Geography

7.1. Key findings
7.2. Introduction
- 7.2.1. Diabetic Retinopathy Market Assessment, By Geography, 2019-2032 (USD Billion)
7.3. Diabetic Retinopathy Market - North America
- 7.3.1. North America: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
- 7.3.2. North America: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
- 7.3.3. Diabetic Retinopathy Market - U.S.
  - 7.3.3.1. U.S.: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
  - 7.3.3.2. U.S.: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
- 7.3.4. Diabetic Retinopathy Market - Canada
  - 7.3.4.1. Canada: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
  - 7.3.4.2. Canada: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
7.4. Diabetic Retinopathy Market - Europe
- 7.4.1. Europe: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
- 7.4.2. Europe: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
- 7.4.3. Diabetic Retinopathy Market - UK
  - 7.4.3.1. UK: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
  - 7.4.3.2. UK: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
- 7.4.4. Diabetic Retinopathy Market - France
  - 7.4.4.1. France: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
  - 7.4.4.2. France: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
- 7.4.5. Diabetic Retinopathy Market - Germany
  - 7.4.5.1. Germany: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
  - 7.4.5.2. Germany: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
- 7.4.6. Diabetic Retinopathy Market - Italy
  - 7.4.6.1. Italy: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
  - 7.4.6.2. Italy: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
- 7.4.7. Diabetic Retinopathy Market - Spain
  - 7.4.7.1. Spain: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
  - 7.4.7.2. Spain: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
- 7.4.8. Diabetic Retinopathy Market - Netherlands
  - 7.4.8.1. Netherlands: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
  - 7.4.8.2. Netherlands: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
- 7.4.9. Diabetic Retinopathy Market - Russia
  - 7.4.9.1. Russia: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
  - 7.4.9.2. Russia: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
7.5. Diabetic Retinopathy Market - Asia Pacific
- 7.5.1. Asia Pacific: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
- 7.5.2. Asia Pacific: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
- 7.5.3. Diabetic Retinopathy Market - China
  - 7.5.3.1. China: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
  - 7.5.3.2. China: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
- 7.5.4. Diabetic Retinopathy Market - India
  - 7.5.4.1. India: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
  - 7.5.4.2. India: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
- 7.5.5. Diabetic Retinopathy Market - Malaysia
  - 7.5.5.1. Malaysia: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
  - 7.5.5.2. Malaysia: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
- 7.5.6. Diabetic Retinopathy Market - Japan
  - 7.5.6.1. Japan: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
  - 7.5.6.2. Japan: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
- 7.5.7. Diabetic Retinopathy Market - Indonesia
  - 7.5.7.1. Indonesia: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
  - 7.5.7.2. Indonesia: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
- 7.5.8. Diabetic Retinopathy Market - South Korea
  - 7.5.8.1. South Korea: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
  - 7.5.8.2. South Korea: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
7.6. Diabetic Retinopathy Market - Middle East & Africa
- 7.6.1. Middle East & Africa: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
- 7.6.2. Middle East & Africa: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
- 7.6.3. Diabetic Retinopathy Market - Saudi Arabia
  - 7.6.3.1. Saudi Arabia: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
  - 7.6.3.2. Saudi Arabia: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
- 7.6.4. Diabetic Retinopathy Market - UAE
  - 7.6.4.1. UAE: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
  - 7.6.4.2. UAE: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
- 7.6.5. Diabetic Retinopathy Market - Israel
  - 7.6.5.1. Israel: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
  - 7.6.5.2. Israel: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
- 7.6.6. Diabetic Retinopathy Market - South Africa
  - 7.6.6.1. South Africa: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
  - 7.6.6.2. South Africa: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
7.7. Diabetic Retinopathy Market - Latin America
- 7.7.1. Latin America: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
- 7.7.2. Latin America: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
- 7.7.3. Diabetic Retinopathy Market - Mexico
  - 7.7.3.1. Mexico: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
  - 7.7.3.2. Mexico: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
- 7.7.4. Diabetic Retinopathy Market - Brazil
  - 7.7.4.1. Brazil: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
  - 7.7.4.2. Brazil: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
- 7.7.5. Diabetic Retinopathy Market - Argentina
  - 7.7.5.1. Argentina: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
  - 7.7.5.2. Argentina: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)

8. Competitive Landscape

8.1. Expansion and Acquisition Analysis
- 8.1.1. Expansion
- 8.1.2. Acquisitions
8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

9.1. Bayer
- 9.1.1. Company Overview
- 9.1.2. Financial Performance
- 9.1.3. Product Benchmarking
- 9.1.4. Recent Development
9.2. Allergan
- 9.2.1. Company Overview
- 9.2.2. Financial Performance
- 9.2.3. Product Benchmarking
- 9.2.4. Recent Development
9.3. Novartis
- 9.3.1. Company Overview
- 9.3.2. Financial Performance
- 9.3.3. Product Benchmarking
- 9.3.4. Recent Development
9.4. Oxurion
- 9.4.1. Company Overview
- 9.4.2. Financial Performance
- 9.4.3. Product Benchmarking
- 9.4.4. Recent Development
9.5. Sirnaomics
- 9.5.1. Company Overview
- 9.5.2. Financial Performance
- 9.5.3. Product Benchmarking
- 9.5.4. Recent Development
9.6. Genentech
- 9.6.1. Company Overview
- 9.6.2. Financial Performance
- 9.6.3. Product Benchmarking
- 9.6.4. Recent Development
9.7. Alimera Sciences
- 9.7.1. Company Overview
- 9.7.2. Financial Performance
- 9.7.3. Product Benchmarking
- 9.7.4. Recent Development
9.8. Ampio Pharmaceuticals
- 9.8.1. Company Overview
- 9.8.2. Financial Performance
- 9.8.3. Product Benchmarking
- 9.8.4. Recent Development
9.9. BCN Peptides
- 9.9.1. Company Overview
- 9.9.2. Financial Performance
- 9.9.3. Product Benchmarking
- 9.9.4. Recent Development
9.10. Kowa Company
- 9.10.1. Company Overview
- 9.10.2. Financial Performance
- 9.10.3. Product Benchmarking
- 9.10.4. Recent Development

簡介目錄圖表

List of Tables

Table 1 Global Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
Table 2 Global Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
Table 3 Diabetic Retinopathy Market Assessment, By Geography, 2019-2032 (USD Billion)
Table 4 North America: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
Table 5 North America: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
Table 6 U.S.: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
Table 7 U.S.: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
Table 8 Canada: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
Table 9 Canada: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
Table 10 Europe: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
Table 11 Europe: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
Table 12 UK: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
Table 13 UK: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
Table 14 France: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
Table 15 France: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
Table 16 Germany: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
Table 17 Germany: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
Table 18 Italy: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
Table 19 Italy: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
Table 20 Spain: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
Table 21 Spain: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
Table 22 Netherlands: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
Table 23 Netherlands: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
Table 24 Russia: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
Table 25 Russia: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
Table 26 Asia Pacific: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
Table 27 Asia Pacific: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
Table 28 China: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
Table 29 China: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
Table 30 India: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
Table 31 India: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
Table 32 Malaysia: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
Table 33 Malaysia: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
Table 34 Japan: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
Table 35 Japan: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
Table 36 Indonesia: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
Table 37 Indonesia: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
Table 38 South Korea: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
Table 39 South Korea: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
Table 40 Middle East & Africa: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
Table 41 Middle East & Africa: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
Table 42 Saudi Arabia: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
Table 43 Saudi Arabia: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
Table 44 UAE: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
Table 45 UAE: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
Table 46 Israel: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
Table 47 Israel: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
Table 48 South Africa: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
Table 49 South Africa: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
Table 50 Latin America: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
Table 51 Latin America: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
Table 52 Mexico: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
Table 53 Mexico: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
Table 54 Brazil: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
Table 55 Brazil: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)
Table 56 Argentina: Diabetic Retinopathy Market, by Management, 2019-2032 (USD Billion)
Table 57 Argentina: Diabetic Retinopathy Market, by Type, 2019-2032 (USD Billion)

List of Figures

Figure 1 Global Diabetic Retinopathy Market, 2019-2032 (USD Billion)
Figure 2 Integrated Ecosystem
Figure 3 Research Methodology: Top-Down & Bottom-Up Approach
Figure 4 Market by Geography
Figure 5 Porter's Five Forces
Figure 6 Market by Management
Figure 7 Global Diabetic Retinopathy Market, by Management, 2022 & 2032 (USD Billion)
Figure 8 Market by Type
Figure 9 Global Diabetic Retinopathy Market, by Type, 2022 & 2032 (USD Billion)
Figure 10 Diabetic Retinopathy Market Assessment, By Geography, 2019-2032 (USD Billion)
Figure 11 Strategic Analysis - Diabetic Retinopathy Market